Skip to content
Catalyst
Sign in

PapersPMID:29291429

Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.

Metabolism: clinical and experimental2018The record ↗

01 · finding
1
02 · compound
1
03 · endpoint
1
04 · null
1
  1. Finding, very limited evidenceno effectHDL cholesterol

Every finding here is a null result.

What did not

1 findingHow to read these marks →
  • curcumin — no detected effect on HDL cholesterol

    very limitedFindingNull resultreplicated ×8

    “Plasma HDL-cholesterol and TG concentrations remained unchanged across all groups.”
    Quoted verbatim from Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolaemic individuals. A randomised controlled trial.
    Study
    RCT
    Duration
    4 weeks
    Dose studied
    200 mg/day
    Population
    hypercholesterolaemic adults; 2×2 factorial trial (placebo, phytosterols 2 g/d, curcumin 200 mg/d, or phytosterols+curcumin combined), result reported across all four trial arms

    Permalink

Study record

Read under
curcumin
Design
randomised controlled trial
Species
human
Population
hypercholesterolaemic adults, mean fasting TC 6.57 ± 0.13 mmol/L
Participants
70
Comparator
placebo
Duration
28 days
Endpoints measured
7
Record
extracted
Readings recorded
2